Browse > Article

Synergistic Antimicrobial Effect of Achyranthes japonica Nakai Extracts and Bifidobacterium Supernatants Against Clostridium difficile  

Jung, Sun-Mi (Department of Biological Engineering, Inha University)
Choi, Soo-Im (Department of Biological Engineering, Inha University)
Park, Sang-Min (Department of Biological Engineering, Inha University)
Heo, Tae-Ryeon (Department of Biological Engineering, Inha University)
Publication Information
Food Science and Biotechnology / v.17, no.2, 2008 , pp. 402-407 More about this Journal
Abstract
The synergistic antimicrobial effect of Achyranthes japonica Nakai (AJN) and Bifidobacterium extracellular factors against Clostridium difficile were measured using a turbidity method. Each broth supernatant of Bifidobacterium infantis ($68.8{\pm}0.02%$) and Bifidobacterium adolescentis ($33.2{\pm}0.2%$) obtained by adding ethyl acetate soluble fractionate from A. japonica Nakai ethanolic extracts (AJNEA, 100 ppm, no inhibition) showed high synergistic antimicrobial activity against C. difficile. In addition, the antimicrobial activity in a laboratory medium and yogurt products against C. difficile were evaluated. In yogurt prepared with a starter 5 (Lactobacillus acidophilus: Streptococcus thermophilus: B. adolescentis =1 : 1 : 1) and a starter 4 (L. acidophilus: S. thermophilus: B. infantis=1 : 1 : 1) and 0.5% AJNEA powder, high antimicrobial effects were recorded that measured 79.0 and 65.2%, respectively. The results indicated the potential of AJN extract for use as an antimicrobial agent. In addition, the efficiency of the antimicrobial activity of the extracts was further improved in combination with lactic acid bacteria, which suggests that they have the potential to be used as a highly effective antibiotic-tolerant microorganism prevention system. Such a strategy can be used for alternative drugs or functional food additives for treatment of antibiotic-associated diarrhea.
Keywords
Achyranthes japonica Nakai; Clostridium difficile; lactic acid bacteria; synergistic antimicrobial effect; yogurt;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
Times Cited By Web Of Science : 1  (Related Records In Web of Science)
Times Cited By SCOPUS : 1
연도 인용수 순위
1 Freeman J, Wilcox MH. Antibiotics and Clostridium difficile. Microbes Infect. 1: 377-384 (1999)   DOI   ScienceOn
2 Homma N. Bifidobacteria as are resistance factor in human beings. Bifidobact. Microfl. 7: 35-43 (1988)   DOI
3 Colombel JF, Cortot A, Neut C, Romond C. Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects. Lancet 330: 43 (1987)
4 Gorbach SL. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet 330: 1519 (1987)
5 Van-Niel CW, Feudtner C, Garrison MN, Christakis DA. Lactobacillus therapy for acute infectious diarrhoea in children: A meta analysis. Pediatrics 109: 678-684 (2002)   DOI   ScienceOn
6 Vanderhoof JA, Whitney DB, Antonson DL, Hanner TL, Lupo JV, Young RJ. Lactobacillus GG in the prevention of antibioticassociated diarrhea in children. J. Pediatr. 135: 564-568 (1999)   DOI   ScienceOn
7 Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-controlled study of the efficacy of lactinex in the prophylaxis of amoxicillin-induced diarrhea. Drug Intel. Clin. Phar. 24: 382-384 (1990)
8 Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R, Kirkkola AL. Effect of Lactobacillus GG yogurt in prevention of antibiotic associated diarrhoea. Ann. Med. 22: 57-59 (1990)   DOI   ScienceOn
9 Kim JT, Jung HY, Lee NK, Rhim SL, Paik HD. Isolation, identification, and probiotic properties of Lactobacillus reuteri HY701 from human feces. Food Sci. Biotechnol. 15: 677-682 (2006)   과학기술학회마을
10 Araki T, Shinozaki T, Irie Y, Miyazawa Y. Trial of oral administration of Bifidobacterium breve for the prevention of rotavirus infection. Kansenshogaku Zasshi 73: 305-310 (1999)   DOI
11 Takemoto T, Ogawa S, Nishimoto N, Hirayama H, Taniguchi S. Studies on the constituents of Achyranthis radix. VII. The insectmoulting substances in Achyranthes and Cyathula genera 'supplement'. Yakuga. Zasshi 88: 1293-1297 (1968)   DOI
12 Saavadra JM, Bauman NA, Oung I, Perman JA, Yolken RH. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344: 1046-1069 (1994)   DOI   ScienceOn
13 Bae HS, Shin MS, Kim YJ, Baek YJ. Effects of the lactic acid bacteria administration on fecal microflora and putrefactive metabolites in health adults. J. Appl. Microbiol. Biotechnol. 24: 254-260 (1996)
14 Bergogne-Berezin E. Treatment and prevention of antibiotic associated diarrhea. Int. J. Antimicrob. Ag. 16: 521-526 (2000)   DOI   ScienceOn
15 Lee YJ, Yu WK, Heo TR. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Ag. 21: 340-346 (2003)   DOI   ScienceOn
16 Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. New Engl. J. Med. 330: 257-262 (1994)   DOI   ScienceOn
17 Black FT, Andersen PL, Orskov J, Orskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacillus on traveller's diarrhoea. Travel Med. 7: 333-335 (1989)
18 Mark P. The effect of probiotics on Clostridium difficile diarrhea. Am. J. Gastroenterol. 95: 11-13 (2000)   DOI
19 Surawicz CM. Probiotics, antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in humans. Best Pract. Res. Cl. Ga. 17: 775-783 (2003)   DOI
20 Cartmill TD, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management of diarrhoea due to Clostridium difficile. J. Hosp. Infect. 27: 1-15 (1994)   DOI   ScienceOn
21 Lyerly DM, Saum KE, MacDonald DK, Wilkins TD. Effects of Clostridim difficile toxins given intragastrically to animals. Infect. Immun. 47: 349-352 (1985)
22 Orrhage K, Brismar B, Nord CE. Effects of supplements of Bifidobacterium longum and Lactobacillus acidophilus on the intestinal microbiota during administration of clindamycin. Microb. Ecol. Health D. 7: 17-25 (1994)   DOI   ScienceOn
23 McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nocosomial acquisition of Clostridium difficile infection. New Eng. J. Med. 320: 204-210 (1989)   DOI   ScienceOn
24 Lee YM, Choi SI, Lee JW, Jung SM, Park SM, Heo TR. Isolation of hyaluronidase inhibitory component from the roots of Astragalus membranaceus Bunge (Astragali radix). Food Sci. Biotechnol. 14: 263-267 (2005)
25 Isolauri E, Juntunen M, Rautanen T. A human Lactobacillus strain (Lactobacillus casei sp. GG) promotes recovery from acute diarrhoea in children. Pediatrics 88: 90-97 (1991)
26 Isolauri E, Kaila M, Mykkanen H. Oral bacteriotherapy for viral gastroenteritis. Digest Dis. Sci. 39: 2595-2600 (1994)   DOI   ScienceOn
27 Son KH, Hwang JH, Lee SH, Park JH, Kang SJ, Chang SY, Lee KS. Isolation and quantitative determination of 20-hydroxyecdysone from Achyranthis radix. Korean J. Pharmacogn. 30: 335-339 (1999)
28 Sehgal M, Kyne L. Clostridium difficile Disease. Curr. Opin. Infect. Dis. 4: 201-210 (2002)   DOI   ScienceOn
29 Takemoto T, Ogawa S, Nishimoto N. Studies on the constituents of Achyranthis radix. II. Isolation of the insectmoulting hormones. Yakuga. Zasshi 87: 1469-1473 (1967)   DOI
30 Bartlett JG. Clostridium difficile: History of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis. 18: 5265-5275 (1994)
31 Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastr. Nutr. 20: 333-338 (1995)   DOI   ScienceOn
32 Gilliland SE. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 87: 175-188 (1990)   DOI
33 Mitsuoka T. Bifidobacteria and their role in human health. J. Ind. Microbiol. 6: 263- 268 (1990)   DOI
34 Kim KT, Yeo EJ, Han YS, Nah SY, Paik HD. Antimicrobial, antiinflammatory, and anti-oxidative effects of water and ethanol extracted Brazilian propolis. Food Sci. Biotechnol. 14: 474-478 (2005)